Zobrazeno 1 - 5
of 5
pro vyhledávání: '"E Serramontmany Morante"'
Autor:
L García Basas, C Varon-Galcera, P Garcia Ortega, E Serramontmany Morante, S Gimenez Giner, M Carreres Prieto, P Rovira Torres, I Cidoncha Muñoz, MQ Gorgas Torner
Publikováno v:
Section 5: Patient safety and quality assurance.
Autor:
P Garcia Ortega, E Serramontmany Morante, L Garcia Basas, P Latorre García, P Rovira Torres, L Manos Pujol, I Cidoncha Muñoz, MQ Gorgas Torner
Publikováno v:
Section 5: Patient safety and quality assurance.
Autor:
E Serramontmany Morante, I Cardona-Pascual, P Garcia Ortega, M Carreras Soler, MQ Gorgas Torner, I Cidoncha Muñoz, E Felip Font
Publikováno v:
Section 6: Education and research.
Autor:
P Garcia Ortega, E Serramontmany Morante, L Garcia Basas, P Latorre Garcia, P Rovira Torres, L Maños Pujol, I Cidoncha Muñoz, MQ Gorgas Torner
Publikováno v:
Section 4: Clinical pharmacy services.
Autor:
L Betriu Sebastia, C Alonso Martinez, JB Montoro Ronsano, E. Lozano Ortín, M Garau Gomila, E Serramontmany Morante, A Roig Izquierdo
Publikováno v:
Eur J Hosp Pharm
BACKGROUND: Intravenous immunoglobulin (IVIG) is the standard of care for humoral immunodeficiencies (HID) and several systemic autoimmune diseases. Its chronic administration represents an important economic and logistical impact. PURPOSE: To assess
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e3dfb7f7e3771f6f52948b4daa23fc6
https://europepmc.org/articles/PMC7535818/
https://europepmc.org/articles/PMC7535818/